Neogen Corporation

NASDAQ:NEOG

Medical - Diagnostics & Research

Healthcare
$11.08 +1.79%

+$0.16 today

Market cap
$2.42B
Beta
1.80
P/E (TTM)
-3.3
EPS (TTM)
-$2.80
52W Low $4.56High $11.43

Volume 1.79M

Average 2.53M

NEOG EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Neogen CorporationNASDAQ: NEOG

EBITDA · Q1 FY2027 · quarter ended Aug 2026

EBITDA dips below year-ago levels

Q1 FY2027 EBITDA of $28M fell 68.6% year over year, behind the +112.0% change in trailing-twelve-month EBITDA. Sequentially, it fell 10.3% from the prior quarter. Over 3 fiscal years it compounded at +9.9% a year.

Context

  • EBITDA amounted to 18.9% of revenue in FY2026, down 85.9 pp from a year earlier.
  • EBITDA increased in 2 of the last 3 fiscal years.

What to watch

Whether EBITDA reaches the consensus estimate from 4 analysts of $257.27M (+56.0%) for the fiscal year ending May 2027, a slowdown from the +117.6% reported in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterAug 2026
$28M-10.3% QoQ
Last fiscal yearMay 2026
$164.9M+117.6% YoY
LTMAug 2026
$105.13M+112.0% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-68.6%+149.9%+218.6 pp
1 year+117.6%+56.0%-61.6 pp
3-year CAGR+9.9%+24.7%+14.9 pp
5-year CAGR+12.3%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2026
164.9M USD
Year-over-year change
+117.6%
4-year CAGR
+18.2%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How NEOG compares with its peers on the latest reported figures

  • NEOG's LTM Aug 2026 EBITDA of $105.13M is the lowest of the 7 companies compared; the peer median is $1.15B.
  • Its year-over-year change of +112.0% is the highest of 7, against a peer median of +4.6%.
  • EBITDA amounts to 11.9% of revenue for NEOG, versus a peer median of 22.9%.
NEOG Competitors Peer median
EBITDA for NEOG and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MRKMerck & Co., Inc.LTM Jun 2026$13.93B -44.4%+9.9%21.0%
ZTSZoetis Inc.LTM Jun 2026$3.99B -1.1%+6.6%42.0%
IDXXIDEXX Laboratories, Inc.LTM Sep 2026$1.62B +11.9%+14.1%34.9%
ELANElanco Animal Health IncorporatedLTM Sep 2026$679M -23.8%-7.9%13.2%
BCPCBalchem CorporationLTM Sep 2026$275.03M +10.4%+9.2%24.8%
PAHCPhibro Animal Health CorporationLTM Mar 2026$225.31M +80.1%+7.8%15.0%
NEOGNeogen CorporationLTM Aug 2026$105.13M +112.0%+9.9%11.9%
Peer median (excluding NEOG) $1.15B+4.6%+8.5%22.9%

Competitors are the stored peer set for NEOG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
FY2026
May 2026
Revenue527.16M822.45M924.22M894.66M870.4M
Cost of Revenue284.15M416.49M461.59M473.29M461.9M
Gross Profit243.01M405.96M462.64M421.38M408.5M
Gross Margin46.1%49.4%50.1%47.1%46.9%
Research & Development17.05M26.04M22.48M21.09M18.4M
Selling, General & Admin167.35M342.4M382.76M401.97M411.7M
Operating Expenses184.4M368.44M385.21M411.96M430.1M
Depreciation & Amortization24.13M90.47M121.23M125.67M116.3M
EBITDA84.34M124.39M182.6M(937.75M)164.9M
EBITDA Margin16.0%15.1%19.8%-104.8%18.9%
Operating Income58.62M37.52M77.43M9.42M(21.6M)
Operating Margin11.1%4.6%8.4%1.1%-2.5%
Interest Income1.34M3.17M6.36M3.11M0
Interest Expense72K55.96M73.39M71.62M57.6M
Other Income / Expenses1.59M(59.56M)(91.73M)(1.14B)12.6M
Income Before Tax60.21M(22.04M)(14.31M)(1.13B)(9M)
Pre-Tax Margin11.4%-2.7%-1.5%-126.7%-1.0%
Income Tax Expense11.9M828K(4.88M)(41.07M)(1.1M)
Net Income48.31M(22.87M)(9.42M)(1.09B)(7.9M)
Net Margin9.2%-2.8%-1.0%-122.1%-0.9%
EPS (Basic)0.45(0.12)(0.04)(5.03)(0.04)
EPS (Diluted)0.45(0.12)(0.04)(5.03)(0.04)
Weighted Avg Shares107.68M188.88M216.48M216.89M217.5M
Weighted Avg Shares (Diluted)108.02M188.88M216.48M216.89M217.5M

Neogen Corporation

NASDAQ:NEOG

Intrinsic Alpha fair value

Locked

Current Price

$11.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.